Sana Biotechnology (SANA) Depreciation & Amortization (CF) (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 34.23% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (down 24.91% YoY), and the FY2025 full-year result was $12.8 million, down 17.42% from the prior year.
• Depreciation & Amortization (CF) eased to $2.4 million in Q1 2026, from $3.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.5 million in Q2 2023 to a low of $2.4 million in Q1 2026.
• A 5-year average of $3.8 million and a median of $3.8 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) soared 60.21% in 2022 and slumped 34.23% in 2026, its largest moves.
• Tracing SANA's Depreciation & Amortization (CF) over 5 years: stood at $4.2 million in 2022, then grew by 0.72% to $4.2 million in 2023, then slipped by 9.52% to $3.8 million in 2024, then fell by 18.42% to $3.1 million in 2025, then dropped by 22.58% to $2.4 million in 2026.
• Business Quant data shows SANA's Depreciation & Amortization (CF) at $2.4 million in Q1 2026, $3.1 million in Q4 2025, and $3.2 million in Q3 2025.